Kamada (KMDA) Inventory Average (2012 - 2026)
Kamada's (KMDA) quarterly Inventory Average came in at $86.2 million in Q2 2026, up 7.4% on a YoY basis from $80.2 million in Q2 2025, and up 1.13% quarter-over-quarter from $85.2 million in Q1 2026.
Analysis
Kamada (KMDA) Inventory Average (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Inventory Average for 15 consecutive years, with $86.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Inventory Average rose 7.4% year-over-year to $86.2 million; the trailing twelve-month figure through Jun 2026 stood at $86.2 million (up 7.4% YoY), and the FY2025 full-year result was $81.9 million, down 2.11% from the prior year.
- Inventory Average advanced to $86.2 million in Q2 2026 per KMDA's latest filing, from $85.2 million in the prior quarter.
- Across five years, Inventory Average topped out at $86.4 million in Q1 2024 and bottomed at $64.6 million in Q2 2022.
- Historically, Inventory Average has averaged $77.8 million across 5 years, with a median of $79.3 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Inventory Average jumped 58.93% in 2022, then slipped 9.06% in 2025.
- Over 5 years, Inventory Average stood at $70.9 million in 2022, then grew by 14.43% to $81.1 million in 2023, then decreased by 7.33% to $75.2 million in 2024, then advanced by 13.29% to $85.2 million in 2025, then increased by 1.15% to $86.2 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $86.2 million, $85.2 million, and $85.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.30 Bn | 197.31 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 180.97 Bn | 177.79 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 132.27 Bn | 124.42 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 82.93 Bn | 74.93 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 61.53 Bn | 56.35 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.27 Bn | 49.13 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.46 Bn | 31.15 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.16 Bn | 29.88 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 30.08 Bn | 30.08 Bn | 1.16 Mn | - |
| 10 | Kamada | 473.85 Mn | 403.72 Mn | 22.47 Mn | 86.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.16 Mn |
| Mar 31, 2026 | 85.19 Mn |
| Dec 31, 2025 | 85.18 Mn |
| Sep 30, 2025 | 83.75 Mn |
| Jun 30, 2025 | 80.22 Mn |
| Mar 31, 2025 | 78.59 Mn |
| Dec 31, 2024 | 75.19 Mn |
| Sep 30, 2024 | 75.14 Mn |
| Jun 30, 2024 | 81.53 Mn |
| Mar 31, 2024 | 86.41 Mn |
| Dec 31, 2023 | 81.14 Mn |
| Sep 30, 2023 | 77.02 Mn |
| Jun 30, 2023 | 80.00 Mn |
| Mar 31, 2023 | 74.27 Mn |
| Dec 31, 2022 | 70.91 Mn |
| Sep 30, 2022 | 68.77 Mn |
| Jun 30, 2022 | 64.64 Mn |
| Mar 31, 2022 | 66.09 Mn |
| Dec 31, 2021 | 57.79 Mn |
| Sep 30, 2021 | 46.38 Mn |